Stress-evoked opioid release inhibits pain in major depressive disorder

Pain

Volumn 139, Issue 2, 2008, Pages 284-292

  Frew, Ashley K ^a   Drummond, Peter D ^a  

^a MURDOCH UNIVERSITY   (Australia)

Author keywords

Cold pressor; Major depressive disorder; Naltrexone; Negative affect; Stress induced analgesia

Indexed keywords

NALTREXONE; OPIATE ANTAGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; PLACEBO;

ADOLESCENT; ADULT; ARITHMETIC; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFECT; ELECTRIC SHOCK; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PAIN; PRIORITY JOURNAL; SHOCK; STRESS;

ADULT; ANALGESICS, OPIOID; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PLACEBO EFFECT; STRESS, PSYCHOLOGICAL;

EID: 53049107723     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.04.022     Document Type: Article

References (51)

1. Amit Z., and Galina Z.H. Stress-induced analgesia: adaptive pain suppression. Physiol Rev 66 (1986) 1091-1120
2. Bandura A., O'Leary A., Taylor C.B., Gauthier J., and Gossard D. Perceived self-efficacy and pain control: opioid and nonopioid mechanisms. J Pers Soc Psychol 53 (1987) 563-571
3. Bandura A., Cioffi D., Taylor B., and Brouillard M. Perceived self-efficacy in coping with cognitive stressors and opioid activation. J Pers Social Psychol 55 (1988) 479-488
4. Banks S.M., and Kerns R.D. Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psychol Bull 119 (1996) 95-110
5. Bastuerk M., Muhtaroglu S., Karaaslan M.F., Oguz A., Simsek A., and Reyhancan M. The relationship between basal plasma beta-endorphin levels and the severity of major depressive disorders. Klinik Psikofarmakoloji Buelteni 10 (2000) 117-120
6. Beck A.T., Steer R.A., and Brown G.K. Beck depression inventory. 2nd ed. (1996), The Psychological Corporation/Harcourt Brace & Company, New York
7. Bencherif B., Fuchs P.N., Sheth R., Dannals R.F., Campbell J.N., and Frost J.J. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET). Pain 99 (2002) 589-598
8. Blazer D.G., Kessler R.C., McGonagle K.A., and Swartz M.S. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 151 (1994) 979-986
9. Bruehl S., McCubbin J.A., and Harden R.N. Theoretical review: altered pain regulatory systems in chronic pain. Neurosci Biobehav Rev 23 (1999) 877-890
10. Buchsbaum M.S., Davis G.C., and Bunney Jr. W.E. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature 270 (1977) 620-622
11. Crabtree B.L. Review of naltrexone, a long-acting opiate antagonist. Clin Pharm 3 (1984) 273-280
12. Darko D.F., Risch S.C., Gillin J.C., and Golshan S. Association of beta-endorphin with specific clinical symptoms of depression. Am J Psychiatry 149 (1992) 1162-1167
13. Davis G.C., Buchsbaum M.S., and Bunney Jr. W.E. Analgesia to painful stimuli in affective illness. Am J Psychiatry 136 (1979) 1148-1151
14. Dickens C., McGowan L., and Dale S. Impact of depression on experimental pain perception: a systematic review of the literature with meta-analysis. Psychosom Med 65 (2003) 369-375
15. Dworkin R.H., Clark W.C., and Lipsitz J.D. Pain responsivity in major depression and bipolar disorder. Psychiatry Res 56 (1995) 173-181
16. El-Sobky A., Dostrovsky J.O., and Wall P.D. Lack of effect of naloxone on pain perception in humans. Nature 263 (1976) 783-784
17. Fillingim R.B., and Maixner W. Gender differences in response to noxious stimuli. Pain Forum 4 (1995) 209-221
18. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders: clinician version (1997), American Psychiatric Press, NY, USA
19. Fishbain D.A., Cutler R., Rosomoff H.L., and Rosomoff R.S. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13 (1997) 116-137
20. Frew A.K., and Drummond P.D. Negative affect, pain and sex: the role of endogenous opioids. Pain 132 Suppl. 1 (2007) S77-S85
21. Gonzalez J.P., and Brogden R.N. Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 35 (1988) 192-213
22. Goodwin G.M., Austin M.P., Curran S.M., Ross M., Murray C., Prentice N., et al. The elevation of plasma beta-endorphin levels in major depression. J Affect Disord 29 (1993) 281-289
23. Grevert P., and Goldstein A. Endorphins: naloxone fails to alter experimental pain or mood in humans. Science 199 (1978) 1093-1095
24. Henkel V., Bussfeld P., Moller H.J., and Hegerl U. Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression?. Eur Arch Psychiatry Clin Neurosci 252 (2002) 240-249
25. Imbe H., Iwai-Liao Y., and Senba E. Stress-induced hyperalgesia: animal models and putative mechanisms. Front Biosci 11 (2006) 2179-2192
26. Janssen S.A. Negative affect and sensitization to pain. Scand J Psychol 43 (2002) 131-137
27. Janssen S.A., and Arntz A. Real-life stress and opioid-mediated analgesia in novice parachute jumpers. J Psychophysiol 15 (2001) 106-113
28. Jungkunz G., Engel R.R., King U.G., and Kuss H.J. Endogenous opiates increase pain tolerance after stress in humans. Psychiatry Res 8 (1983) 13-18
29. Keay K.A., and Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 25 (2001) 669-678
30. Kennedy S.E., Koeppe R.A., Young E.A., and Zubieta J.K. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 63 (2006) 1199-1208
31. Kivioja J., Sjalin M., and Lindgren U. Psychiatric morbidity in patients with chronic whiplash-associated disorder. Spine 29 (2004) 1235-1239
32. Kudoh A., Katagai H., and Takazawa T. Increased postoperative pain scores in chronic depression patients who take antidepressants. J Clin Anesth 14 (2002) 421-425
33. Lautenbacher S., Roscher S., Strian D., Fassbender K., Krumrey K., and Krieg J.C. Pain perception in depression: relationships to symptomatology and naloxone-sensitive mechanisms. Psychosom Med 56 (1994) 345-352
34. Lautenbacher S., Spernal J., Schreiber W., and Krieg J.C. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med 61 (1999) 822-827
35. Liberzon I., Zubieta J.K., Fig L.M., Phan K.L., Koeppe R.A., and Taylor S.F. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Proc Natl Acad Sci USA 99 (2002) 7084-7089
36. Lovibond S.H., and Lovibond P.H. Depression, anxiety, stress scales (1995), Psychology Foundation Monograph, Sydney
37. Marazziti D., Castrogiovanni P., Rossi A., Rosa C., Ghione S., Di Muro A., et al. Pain threshold is reduced in depression. Int J Neuropsychopharmacol 1 (1998) 45-48
38. Pitman R.K., van der Kolk B.A., Orr S.P., and Greenberg M.S. Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study. Arch Gen Psychiatry 47 (1990) 541-544
39. Ribeiro S.C., Kennedy S.E., Smith Y.R., Stohler C.S., and Zubieta J.K. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1264-1280
40. Robertson L.J., Hammond G.R., and Drummond P.D. The effect of subcutaneous naloxone on experimentally induced pain. J Pain 9 (2008) 79-87
41. Rodgers R.J., and Randall J.I. Environmentally induced analgesia: situational factors, mechanisms and significance. In: Rodgers R.J., and Cooper S.J. (Eds). Endorphins, opiates and behavioural processes (1988), Wiley, New York
42. Romano J.M., and Turner J.A. Chronic pain and depression: does the evidence support a relationship?. Psychol Bull 97 (1985) 18-34
43. Smith Y.R., Stohler C.S., Nichols T.E., Bueller J.A., Koeppe R.A., and Zubieta J.K. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 26 (2006) 5777-5785
44. Spielberger C.D. State-trait anxiety inventory (1983), Consulting Psychologists Press, Inc., CA
45. von Korff M., LeResche L., and Dworkin S.F. First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain 55 (1993) 251-258
46. Weisenfeld-Hallin Z. Sex differences in pain perception. Gender Med 2 (2005) 137-145
47. Willer J.C., Dehen H., and Cambier J. Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science 212 (1981) 689-691
48. Willer J.C., and Ernst M. Somatovegetative changes in stress-induced analgesia in man: an electrophysiological and pharmacological study. Ann NY Acad Sci 467 (1986) 256-272
49. Zis A.P., Haskett R.F., Albala A.A., Carroll B.J., and Lohr N.E. Opioid regulation of hypothalamic-pituitary-adrenal function in depression. Arch Gen Psychiatry 42 (1985) 383-386
50. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 (2001) 311-315
51. Zubieta J.K., Ketter T.A., Bueller J.A., Xu Y., Kilbourn M.R., Young E.A., et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry 60 (2003) 1145-1153